Alfarol (Alfacalcidol)


Indications and Reactions:

Role Indications Reactions
Secondary
Osteoporosis 27.3%
Rheumatoid Arthritis 13.0%
Drug Use For Unknown Indication 10.4%
Pain 6.5%
Hypertension 3.9%
Lumbar Spinal Stenosis 3.9%
Osteitis Deformans 3.9%
Ulcer 3.9%
Adverse Drug Reaction 2.6%
Angina Unstable 2.6%
Autonomic Nervous System Imbalance 2.6%
Gastric Ulcer 2.6%
Hypercholesterolaemia 2.6%
Insomnia 2.6%
Oral Candidiasis 2.6%
Reflux Oesophagitis 2.6%
Urticaria 2.6%
Arteriosclerosis Obliterans 1.3%
Arthritis 1.3%
Gastritis 1.3%
Urticaria 18.2%
Blood Alkaline Phosphatase Increased 9.1%
Hypercalcaemia 9.1%
Interstitial Lung Disease 9.1%
Neutropenia 9.1%
Peripheral Vascular Disorder 9.1%
Pneumonia 9.1%
Red Blood Cell Count Decreased 9.1%
Renal Impairment 9.1%
Urinary Retention 9.1%
Concomitant
Multiple Myeloma 18.3%
Lupus Nephritis 17.4%
Rheumatoid Arthritis 14.6%
Osteoporosis 7.8%
Lung Transplant 6.5%
Hyperphosphataemia 5.3%
Lung Adenocarcinoma 4.3%
Renal Transplant 4.3%
Myasthenia Gravis 3.4%
Crohn's Disease 3.1%
Drug Use For Unknown Indication 2.2%
Juvenile Arthritis 1.9%
Dementia Alzheimer's Type 1.6%
Diabetes Mellitus 1.6%
Infection 1.6%
Cardiac Failure Chronic 1.2%
Osteoporosis Postmenopausal 1.2%
Schizophrenia 1.2%
Systemic Lupus Erythematosus 1.2%
Ulcer 1.2%
White Blood Cell Count Decreased 11.7%
Vomiting 10.6%
Syncope 8.5%
Urinary Tract Infection 8.5%
Pyrexia 6.4%
Rash 5.3%
White Blood Cell Count Increased 5.3%
Ventricular Extrasystoles 4.3%
Visual Acuity Reduced 4.3%
Anaphylactoid Reaction 3.2%
Condition Aggravated 3.2%
Death 3.2%
Glaucoma 3.2%
Myocardial Infarction 3.2%
Platelet Count Decreased 3.2%
Pyelonephritis 3.2%
Renal Impairment 3.2%
Sepsis 3.2%
Shock 3.2%
Stress Fracture 3.2%

Drug Data